Ulla Strömberg

439 total citations
6 papers, 120 citations indexed

About

Ulla Strömberg is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Ulla Strömberg has authored 6 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Genetics and 2 papers in Rheumatology. Recurrent topics in Ulla Strömberg's work include Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Ulla Strömberg is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Ulla Strömberg collaborates with scholars based in Sweden, Norway and Finland. Ulla Strömberg's co-authors include T Strömberg, Anders Wåhlin, Håkan Askmark, Rayomand Press, Cecilia Isaksson, J-E Johansson, H Hägglund, Hans Axelson, Anders Svenningsson and Satu Mustjoki and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Ulla Strömberg

6 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulla Strömberg Sweden	5	55	49	36	27	22	6	120
Kamel Ghomari France	6	49 0.9×	54 1.1×	22 0.6×	45 1.7×	11 0.5×	6	99
Martha Lenis Canada	5	71 1.3×	41 0.8×	52 1.4×	3 0.1×	31 1.4×	17	145
Cristina Calderón‐Cabrera Spain	8	38 0.7×	38 0.8×	16 0.4×	3 0.1×	7 0.3×	16	127
Brian Steingo United States	7	14 0.3×	11 0.2×	62 1.7×	36 1.3×	14 0.6×	12	161
Luis Amselem Spain	7	22 0.4×	15 0.3×	69 1.9×	16 0.6×	21 1.0×	17	233
Quitterie Venot France	5	14 0.3×	12 0.2×	47 1.3×	22 0.8×	4 0.2×	7	125
Alexandra Goodyear United States	4	11 0.2×	17 0.3×	41 1.1×	17 0.6×	5 0.2×	11	111
Claudia Mechi Italy	9	22 0.4×	9 0.2×	49 1.4×	10 0.4×	26 1.2×	12	149
Elise Descamps France	5	8 0.1×	14 0.3×	8 0.2×	42 1.6×	6 0.3×	11	87
Chris TenHoor United States	3	22 0.4×	48 1.0×	12 0.3×	23 0.9×	2 0.1×	5	120

Countries citing papers authored by Ulla Strömberg

Since Specialization

Citations

This map shows the geographic impact of Ulla Strömberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Strömberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Strömberg more than expected).

Fields of papers citing papers by Ulla Strömberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Strömberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Strömberg. The network helps show where Ulla Strömberg may publish in the future.

Co-authorship network of co-authors of Ulla Strömberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Strömberg. A scholar is included among the top collaborators of Ulla Strömberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Strömberg. Ulla Strömberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hochhaus, Andreas, Carlo Gambacorti‐Passerini, Camille N. Abboud, et al.. (2019). PS1176 PRIMARY RESULTS OF THE PHASE 4 BYOND STUDY OF BOSUTINIB FOR PRETREATED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA. HemaSphere. 3(S1). 535–535. 1 indexed citations

2.

Dolinska, Monika B., Eleni Gelali, Anne‐Sofie Johansson, et al.. (2017). Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34+CD38− stem and progenitor cells in chronic myeloid leukemia. Biochemical and Biophysical Research Communications. 490(2). 378–384. 11 indexed citations

3.

Mahon, François‐Xavier, Johan Richter, Joëlle Guilhot, et al.. (2016). Cessation of Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response: Results of the Euro-Ski Trial. Blood. 128(22). 787–787. 35 indexed citations

4.

Hjorth‐Hansen, Henrik, Jesper Stentoft, Johan Richter, et al.. (2015). Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients. Blood. 126(23). 477–477. 8 indexed citations

5.

Press, Rayomand, Håkan Askmark, Anders Svenningsson, et al.. (2013). Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 618–624. 43 indexed citations

6.

Strömberg, Ulla, et al.. (1987). Endodontic treatment of experimentally induced apical periodontitis in dogs. Dental Traumatology. 3(5). 240–244. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact